Tag Archives: Boost

Humana eyes doubling primary care membership, reports MA boost in Q4

Dive Brief: Humana on Wednesday reported revenue for the fourth quarter of 2019 of $ 16.3 billion, a 15% year over year increase that was above Wall Street expectations, and revenue for the full year rose 14% from nearly $ 57 billion to $ 64.8 billion. The payer touted Medicare Advantage membership reaching nearly 3.6 million… Read More »

Medical News Today: Cancer: Using copper to boost immunotherapy

An interdisciplinary group of scientists has successfully destroyed tumor cells in mice by using nano-sized copper compounds alongside immunotherapy. Importantly, the tumors did not return after the treatment ceased. According to the World Health Organization, cancer is the second leading cause of death worldwide — in 2018, it was responsible for approximately 9.6 million deaths.… Read More »

Health-care companies use technology and data to boost primary care services

Hero Images | Hero Images | Getty Images In baseball, high-salaried home run sluggers have always gotten the glory. The equivalent in health-care may be high-priced drugs and medical specialties that help save lives in critical cases. But 20 years ago, there was a big shift baseball. Leveraging data analytics, the Oakland A’s found success… Read More »

India courts private hospitals to boost insurance program

NEW DELHI (Reuters) – India will offer incentives to private hospitals to take part in the government’s health insurance program, potentially the biggest of its kind in the world, a senior government official told Reuters. Indu Bhushan, CEO of India’s National Health Authority (NHA), poses for a picture inside his office after an interview with… Read More »

BMS deal quest gets a boost as Celgene swats aside another Revlimid patent challenge

Much of the investor doubt surrounding Bristol-Myers Squibb’s $ 74 billion Celgene buyout centers on the multiple myeloma blockbuster Revlimid—namely, whether its remaining patents can stand up to legal challenges. But the companies just scored a win in that department. Thursday, the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) decided not… Read More »